Home
Storia in 1 fonti
Migraines do not improve, but health care utilization decreases following GLP-1 initiation
Patients with migraine who began using GLP-1 receptor agonists for obesity did not experience any significant changes in headache outcomes, according to data presented at the American Headache Society 68th Annual Scientific Meeting.However, initiation of these drugs was associated with less health care utilization and treatment escalation compared with topiramate, Scott Yuan, MD, PhD, director,
Raccontata da
healio.com
Timeline cronologica
- ·
GLP-1s may nearly halve risk for hepatic complications in MASLD, type 2 diabetes
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2…
- ·
GLP-1 use tied to lower heart, thrombotic risk in adults with obesity, autoimmune disease
NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and…
- ·
Migraines do not improve, but health care utilization decreases following GLP-1 initiation
Patients with migraine who began using GLP-1 receptor agonists for obesity did not experience any significant changes in headache outcomes, according to data presented at the…